BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23913167)

  • 1. Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.
    Sperga M; Martinek P; Vanecek T; Grossmann P; Bauleth K; Perez-Montiel D; Alvarado-Cabrero I; Nevidovska K; Lietuvietis V; Hora M; Michal M; Petersson F; Kuroda N; Suster S; Branzovsky J; Hes O
    Virchows Arch; 2013 Oct; 463(4):563-73. PubMed ID: 23913167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma.
    Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O
    Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
    Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
    Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma.
    Brunelli M; Gobbo S; Cossu-Rocca P; Cheng L; Hes O; Delahunt B; Pea M; Bonetti F; Mina MM; Ficarra V; Chilosi M; Eble JN; Menestrina F; Martignoni G
    Mod Pathol; 2007 Mar; 20(3):303-9. PubMed ID: 17277768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies.
    Alaghehbandan R; Trpkov K; Tretiakova M; Luis AS; Rogala JD; Hes O
    Adv Anat Pathol; 2021 Jan; 28(1):8-20. PubMed ID: 33021507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis.
    Avulova S; Cheville JC; Lohse CM; Gupta S; Potretzke TA; Tsivian M; Thompson RH; Boorjian SA; Leibovich BC; Potretzke AM
    Eur Urol; 2021 Feb; 79(2):225-231. PubMed ID: 33172723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Profiling Uncovers Genome-Wide Loss of Heterozygosity and Provides Insight into Mechanisms of Sarcomatoid Transformation in Chromophobe Renal Cell Carcinoma.
    Collins K; Acosta AM; Siegmund SE; Cheng L; Hirsch MS; Idrees MT
    Mod Pathol; 2024 Feb; 37(2):100396. PubMed ID: 38043790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas.
    Dagher J; Dugay F; Verhoest G; Cabillic F; Jaillard S; Henry C; Arlot-Bonnemains Y; Bensalah K; Oger E; Vigneau C; Rioux-Leclercq N; Belaud-Rotureau MA
    Hum Pathol; 2013 Oct; 44(10):2106-15. PubMed ID: 23806527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FISH analysis in chromophobe renal-cell carcinoma.
    Iqbal MA; Akhtar M; Ulmer C; Al-Dayel F; Paterson MC
    Diagn Cytopathol; 2000 Jan; 22(1):3-6. PubMed ID: 10613963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic alveolosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma.
    Petersson F; Bulimbasic S; Hes O; Slavik P; Martínek P; Michal M; Gomolčáková B; Hora M; Damjanov I
    Ann Diagn Pathol; 2012 Dec; 16(6):459-69. PubMed ID: 23036259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Genetic Analysis in Correct Diagnosis of Eosinophilic Variant of Chromophobe Renal Cell Carcinoma.
    Molnar A; Yusenko MV; Kovacs G; Banyai D
    Anticancer Res; 2020 Dec; 40(12):6863-6867. PubMed ID: 33288578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.
    Dvorakova M; Dhir R; Bastacky SI; Cieply KM; Acquafondata MB; Sherer CR; Mercuri TL; Parwani AV
    Diagn Pathol; 2010 May; 5():32. PubMed ID: 20497539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
    Baraban EG; Elias R; Lin MT; Ged Y; Zhu J; Pallavajjala A; Singla N; Lotan TL; Argani P; Eshleman JR; Epstein JI
    Mod Pathol; 2024 May; 37(5):100472. PubMed ID: 38492778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of tissue microarrays for assessment of chromosomal abnormalities in chromophobe renal cell carcinoma.
    Brunelli M; Delahunt B; Ficarra V; Gobbo S; Eccher A; Cossu-Rocca P; Zattoni F; Cheng L; Eble JN; Martignoni G
    Anal Quant Cytol Histol; 2009 Dec; 31(6):401-9. PubMed ID: 20698356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276).
    Yang Y; Vocke CD; Ricketts CJ; Wei D; Padilla-Nash HM; Lang M; Sourbier C; Killian JK; Boyle SL; Worrell R; Meltzer PS; Ried T; Merino MJ; Metwalli AR; Linehan WM
    Genes Chromosomes Cancer; 2017 Oct; 56(10):719-729. PubMed ID: 28736828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis.
    Chen CV; Croom NA; Simko JP; Stohr BA; Chan E
    Hum Pathol; 2022 Jan; 119():85-93. PubMed ID: 34800526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?
    Hes O; Condom Mundo E; Peckova K; Lopez JI; Martinek P; Vanecek T; Falconieri G; Agaimy A; Davidson W; Petersson F; Bulimbasic S; Damjanov I; Jimeno M; Ulamec M; Podhola M; Sperga M; Pane Foix M; Shelekhova K; Kalusova K; Hora M; Rotterova P; Daum O; Pivovarcikova K; Michal M
    Am J Surg Pathol; 2016 May; 40(5):664-75. PubMed ID: 26999503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.